Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
JAMA
    April 2024
  1. RUBIN R
    All of Us Program Illustrates What Less-Diverse Genomics Studies Might Be Missing.
    JAMA. 2024;331:1167-1168.
    >> Share

  2. HARRIS E
    Less Sleep Tied to Increased Risk of Diabetes Despite Healthy Diet.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4498.
    >> Share

  3. FANG M, Wang D, Selvin E
    Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.
    JAMA. 2024 Apr 4. doi: 10.1001/jama.2024.2103.
    >> Share

  4. POURKARIM F, Entezari-Maleki T
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1380.
    >> Share

  5. BOGGESS KA
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1383.
    >> Share

    March 2024
  6. MOZAFFARIAN D
    GLP-1 Agonists for Obesity-A New Recipe for Success?
    JAMA. 2024;331:1007-1008.
    >> Share

  7. THOMAS CC, Chopra K, Davis AM
    Management of Outpatients With Diabetes at High Risk of Hypoglycemia.
    JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.1137.
    >> Share

  8. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    >> Share

  9. RUDER K
    Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could Move the Needle.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
    >> Share

    February 2024
  10. WADDEN TA, Kushner RF, Chao AM
    Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    JAMA. 2024;331:643-645.
    >> Share

  11. COURCOULAS AP, Patti ME, Hu B, Arterburn DE, et al
    Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024;331:654-664.
    >> Share

  12. MENG J, Tang H, Gao S
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:617-618.
    >> Share

  13. PARK Y, Kim NE, Lee SJ
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:618.
    >> Share

  14. DUNNE F, Newman C, Smyth A
    Early Metformin Treatment for Gestational Diabetes-Reply.
    JAMA. 2024;331:618-619.
    >> Share

  15. CRANE MA, Lam A, Ekanayake E, Alshawkani YY, et al
    Mortality Due to Hyperglycemic Crises in the US, 1999-2022.
    JAMA. 2024;331:440-442.
    >> Share

  16. ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
    Delivery Device Patents on GLP-1 Receptor Agonists.
    JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
    >> Share

    January 2024
  17. BELL KJL, Glasziou PP, Doust JA
    Gestational Diabetes and Cardiovascular Health.
    JAMA. 2024;331:167.
    >> Share

  18. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Cardiovascular Health-Reply.
    JAMA. 2024;331:167-168.
    >> Share

  19. HARRIS E
    "Alarming" Number of Patients Stop Taking Second-Line Diabetes Drugs.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26110.
    >> Share

  20. HARRIS E
    First Large Study of GLP-1 Receptor Agonists During Pregnancy.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26112.
    >> Share

  21. ARONNE LJ, Sattar N, Horn DB, Bays HE, et al
    Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
    JAMA. 2024;331:38-48.
    >> Share

  22. RUDER K
    At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide.
    JAMA. 2024;331:9-11.
    >> Share

    December 2023
  23. JIN J
    What Is Prediabetes?
    JAMA. 2023;330:2404.
    >> Share

  24. HARRIS E
    Lifestyle Changes Lowered Blood Glucose in People With Prediabetes.
    JAMA. 2023;330:2241.
    >> Share

  25. HARRIS E
    Meta-Analysis: Faster Walking Linked With Lower Type 2 Diabetes Risk.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24686.
    >> Share

  26. FEIG DS
    Metformin for Diabetes in Pregnancy: Are We Closer to Defining Its Role?
    JAMA. 2023;330:2167-2169.
    >> Share

  27. BOGGESS KA, Valint A, Refuerzo JS, Zork N, et al
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial.
    JAMA. 2023;330:2182-2190.
    >> Share

  28. HARRIS E
    Even Mild Lack of Sleep Might Raise Women's Diabetes Risk.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.24174.
    >> Share

    November 2023
  29. HARRIS E
    Semaglutide Improved Cardiovascular Health in People Without Diabetes.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23508.
    >> Share

  30. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    >> Share

  31. VOELKER R
    What Are Diabetic Foot Ulcers?
    JAMA. 2023 Nov 17. doi: 10.1001/jama.2023.17291.
    >> Share

  32. HARRIS E
    Weekly Basal Insulin May Be Equally Effective for Type 1 Diabetes.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22358.
    >> Share

  33. SODHI M, Rezaeianzadeh R, Kezouh A, Etminan M, et al
    Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.
    JAMA. 2023;330:1795-1797.
    >> Share

  34. HARRIS E
    Time-Restricted Eating Tested for Weight Loss in Type 2 Diabetes.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21874.
    >> Share

  35. FENG W, Wang X
    Review of Diabetic Foot Ulcers.
    JAMA. 2023;330:1695.
    >> Share

  36. STRAUSS MB, Wilson K
    Review of Diabetic Foot Ulcers.
    JAMA. 2023;330:1694-1695.
    >> Share

  37. ARMSTRONG DG, Boulton AJM, Bus SA
    Review of Diabetic Foot Ulcers-Reply.
    JAMA. 2023;330:1695-1696.
    >> Share

  38. HARRIS E
    Monoclonal Antibody Slowed Type 1 Diabetes Progression.
    JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21175.
    >> Share

    October 2023
  39. HARRIS E
    Antivirals Might Preserve Insulin in New-Onset Type 1 Diabetes.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.20633.
    >> Share

  40. HARRIS E
    Large Number of People Diagnosed With Type 1 Diabetes After Age 30.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19207.
    >> Share

  41. ROSENSTOCK J, Frias JP, Rodbard HW, Tofe S, et al
    Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.
    JAMA. 2023 Oct 3:e2320294. doi: 10.1001/jama.2023.20294.
    >> Share

  42. DUNNE F, Newman C, Alvarez-Iglesias A, Ferguson J, et al
    Early Metformin in Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Oct 3:e2319869. doi: 10.1001/jama.2023.19869.
    >> Share

    September 2023
  43. HARRIS E
    Semaglutide Associated With Less Insulin Need in Early Type 1 Diabetes.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17818.
    >> Share

  44. HARRIS E
    Staying Up Late Tied to Unhealthful Lifestyle, Increased Diabetes Risk.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17826.
    >> Share

  45. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
    SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
    JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
    >> Share

    August 2023
  46. HSU NC, Fu YC, Hsu CH
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes.
    JAMA. 2023;330:771.
    >> Share

  47. PAGIDIPATI NJ, Granger CB, Nelson A
    Coordinated Care for Optimization of Cardiovascular Preventive Therapies in Patients With Diabetes-Reply.
    JAMA. 2023;330:771-772.
    >> Share

  48. HELGASON H, Eiriksdottir T, Ulfarsson MO, Choudhary A, et al
    Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
    JAMA. 2023;330:725-735.
    >> Share

  49. ALHIARY R, Kesselheim AS, Gabriele S, Beall RF, et al
    Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.
    JAMA. 2023;330:650-657.
    >> Share

  50. VENKATESH KK, Khan SS, Powe CE
    Gestational Diabetes and Long-Term Cardiometabolic Health.
    JAMA. 2023 Aug 10. doi: 10.1001/jama.2023.14997.
    >> Share

  51. ENTEZARI-MALEKI T
    Review of Prediabetes.
    JAMA. 2023;330:563-564.
    >> Share

  52. DAVIDSON MB
    Review of Prediabetes.
    JAMA. 2023;330:564.
    >> Share

  53. DAGOGO-JACK S
    Review of Prediabetes-Reply.
    JAMA. 2023;330:564-565.
    >> Share

    July 2023
  54. HSU NC, Tsai HB, Hsu CH
    Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes.
    JAMA. 2023;330:380.
    >> Share

  55. FORLENZA GP, Schamberger MS, Buckingham BA
    Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply.
    JAMA. 2023;330:380.
    >> Share

  56. ABBASI J
    New Weight Loss Drugs Make Headlines at Diabetes Meeting.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12718.
    >> Share

  57. HARRIS E
    FDA Greenlights First Cell Therapy for Adults With Type 1 Diabetes.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12542.
    >> Share

  58. HARRIS E
    Oral Empagliflozin Receives FDA Approval for Children With Diabetes.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.12057.
    >> Share

  59. ARMSTRONG DG, Tan TW, Boulton AJM, Bus SA, et al
    Diabetic Foot Ulcers: A Review.
    JAMA. 2023;330:62-75.
    >> Share

    June 2023
  60. LINGVAY I, Asong M, Desouza C, Gourdy P, et al
    Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes: The ONWARDS 3 Randomized Clinical Trial.
    JAMA. 2023 Jun 24. doi: 10.1001/jama.2023.11313.
    >> Share

  61. HARRIS E
    Patients With Diabetes Turn to Crowdfunding for Expenses.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10736.
    >> Share

  62. HARRIS E
    Oral Semaglutide Led to Similar Weight Loss as Injection, Company Says.
    JAMA. 2023;329:2011.
    >> Share

  63. SURAN M
    Sugar Substitutes Don't Help Weight Control and May Increase Risk of Heart Disease and Diabetes, WHO Warns.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10967.
    >> Share


  64. The Routine Treatment of Diabetes With Insulin.
    JAMA. 2023;329:1888.
    >> Share

    May 2023
  65. HARRIS E
    FDA Greenlights Automated Insulin Dosing System for Type 1 Diabetes.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9602.
    >> Share

  66. KANCLERZ P, Tuuminen R
    Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy.
    JAMA. 2023;329:1795-1796.
    >> Share

  67. SUN JK, Glassman AR, Maturi RK
    Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy-Reply.
    JAMA. 2023;329:1796.
    >> Share

  68. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
    Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
    JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
    >> Share

    April 2023
  69. HERMAN WH
    Prediabetes Diagnosis and Management.
    JAMA. 2023;329:1157-1159.
    >> Share

  70. ECHOUFFO-TCHEUGUI JB, Perreault L, Ji L, Dagogo-Jack S, et al
    Diagnosis and Management of Prediabetes: A Review.
    JAMA. 2023;329:1206-1216.
    >> Share

    March 2023
  71. HARRIS E
    Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5259.
    >> Share

  72. SURAN M
    All 3 Major Insulin Manufacturers Are Cutting Their Prices-Here's What the News Means for Patients With Diabetes.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2022.11688.
    >> Share

  73. FANG M, Selvin E
    Cost-Related Insulin Rationing in US Adults Younger Than 65 Years With Diabetes.
    JAMA. 2023 Mar 29:e235747. doi: 10.1001/jama.2023.5747.
    >> Share

  74. DEWANE M, Kroshinsky D
    A Patient With Diabetes and Spontaneous Blistering of the Right Lower Extremity.
    JAMA. 2023 Mar 24. doi: 10.1001/jama.2023.3101.
    >> Share

  75. REDFIELD MM, Borlaug BA
    Heart Failure With Preserved Ejection Fraction: A Review.
    JAMA. 2023;329:827-838.
    >> Share

  76. VALENT AM, Caughey AB
    Comprehensive Management of Type 2 Diabetes During Pregnancy.
    JAMA. 2023 Mar 10. doi: 10.1001/jama.2023.0929.
    >> Share

  77. PAGIDIPATI NJ, Nelson AJ, Kaltenbach LA, Leyva M, et al
    Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232854. doi: 10.1001/jama.2023.2854.
    >> Share

  78. AGGARWAL R, Yeh RW, Joynt Maddox KE, Wadhera RK, et al
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.
    JAMA. 2023 Mar 5:e232307. doi: 10.1001/jama.2023.2307.
    >> Share

    February 2023
  79. FORLENZA GP, McVean J, Beck RW, Bauza C, et al
    Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2064.
    >> Share

  80. COUPER J
    Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2140.
    >> Share

  81. MCVEAN J, Forlenza GP, Beck RW, Bauza C, et al
    Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2023 Feb 24. doi: 10.1001/jama.2023.2063.
    >> Share

  82. HARRIS E
    MicroRNAs Expressed in Pancreatic Islets Linked With Type 2 Diabetes.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2097.
    >> Share

  83. HARRIS E
    Meta-analysis: Vitamin D Therapy Reduced Type 2 Diabetes.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1550.
    >> Share

  84. CHANG R
    SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents.
    JAMA. 2023;329:512.
    >> Share

  85. REWERS M, Ziegler AG
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply.
    JAMA. 2023;329:512-513.
    >> Share

  86. SEDERHOLM LAWESSON S, Swahn E, Pihlsgard M, Andersson T, et al
    Association Between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography.
    JAMA. 2023;329:393-404.
    >> Share

  87. MATURI RK, Glassman AR, Josic K, Baker CW, et al
    Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
    JAMA. 2023;329:376-385.
    >> Share

    January 2023
  88. HARRIS E
    Stroke Risk From Diabetes, High Blood Pressure May Decrease With Age.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0390.
    >> Share

  89. SLOMSKI A
    Low-Carbohydrate, High-Fat Diet Improved Type 2 Diabetes Without Restricting Calories.
    JAMA. 2023;329:278.
    >> Share

  90. LARKIN H
    More Adolescents and Young Adults Developing Type 2 Diabetes Around the World.
    JAMA. 2023;329:200.
    >> Share

  91. LARKIN H
    New Drug Delays Type 1 Diabetes Onset.
    JAMA. 2023;329:14.
    >> Share

  92. REDMOND B
    The Scent of Hope.
    JAMA. 2023;329:21-22.
    >> Share

    December 2022
  93. LARKIN H
    Wide Variation in Reported Type 1 Diabetes Incidence in Children Around the World.
    JAMA. 2022;328:2295.
    >> Share

    November 2022
  94. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:1945-1950.
    >> Share

  95. LARKIN HD
    Bionic Pancreas Outperforms Standard Care for Type 1 Diabetes in Trial.
    JAMA. 2022;328:1798-1799.
    >> Share

  96. LARKIN HD
    Cybersecurity Risk for Medtronic Insulin Pump.
    JAMA. 2022;328:1679.
    >> Share

    October 2022
  97. SLOMSKI A
    Trial Compares Glucose-Lowering Drugs for Type 2 Diabetes.
    JAMA. 2022;328:1581.
    >> Share

  98. SLOMSKI A
    Large Treatment Effects With Automated Insulin Delivery System.
    JAMA. 2022;328:1581-1582.
    >> Share

  99. KE C, Lipscombe LL, Weisman A, Zhou L, et al
    Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019.
    JAMA. 2022 Oct 14. pii: 2797494. doi: 10.1001/jama.2022.14914.
    >> Share

  100. LARKIN HD
    Open-source Closed-Loop System Is Effective for Type 1 Diabetes.
    JAMA. 2022;328:1387-1388.
    >> Share

    September 2022
  101. ISGANAITIS E, Laffel L
    Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes.
    JAMA. 2022;328:933-934.
    >> Share

  102. JIN J
    Screening for Type 2 Diabetes in Children and Adolescents.
    JAMA. 2022;328:993.
    >> Share

  103. JONAS DE, Vander Schaaf EB, Riley S, Allison BA, et al
    Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:968-979.
    >> Share

  104. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:963-967.
    >> Share

  105. ESSIEN UR, Washington DL, Fine MJ
    Beyond Detecting and Understanding Disparities in Novel Diabetes Treatment: Need for a Major Shift in Pharmacoequity Research.
    JAMA. 2022;328:836-838.
    >> Share

  106. SLOMSKI A
    Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
    JAMA. 2022;328:817.
    >> Share

  107. LAMPREA-MONTEALEGRE JA, Madden E, Tummalapalli SL, Peralta C, et al
    Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
    JAMA. 2022;328:861-871.
    >> Share

    August 2022
  108. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
    JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
    >> Share

    July 2022
  109. HEYBORNE K, Barbour L
    Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity.
    JAMA. 2022;328:396-397.
    >> Share

  110. GEMMILL A, Leonard SA
    Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity.
    JAMA. 2022;328:397.
    >> Share

  111. VENKATESH KK, Lynch CD, Grobman WA
    Risk of Adverse Pregnancy Outcomes Among US Individuals With Gestational Diabetes by Race and Ethnicity-Reply.
    JAMA. 2022;328:397-398.
    >> Share

  112. SLOMSKI A
    Tirzepatide Trial Demonstrates Substantial Weight Loss.
    JAMA. 2022;328:322.
    >> Share

  113. JIANG C, Cifu AS, Sam S
    Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes.
    JAMA. 2022 Jul 11. pii: 2794311. doi: 10.1001/jama.2022.10338.
    >> Share

    May 2022
  114. SLOMSKI A
    Dapagliflozin Safe and Effective for Heart Failure With Frailty.
    JAMA. 2022;327:1950.
    >> Share

  115. GOODWIN PJ, Chen BE, Gelmon KA, Whelan TJ, et al
    Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
    JAMA. 2022;327:1963-1973.
    >> Share

  116. FANG M, Wang D, Echouffo-Tcheugui JB, Selvin E, et al
    Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations.
    JAMA. 2022;327:1924-1925.
    >> Share

  117. TU WJ, Xue Y, Nie D
    The Prevalence and Treatment of Diabetes in China From 2013 to 2018.
    JAMA. 2022;327:1706.
    >> Share

  118. WANG L, Wu J, Wang Y
    The Prevalence and Treatment of Diabetes in China From 2013 to 2018-Reply.
    JAMA. 2022;327:1706-1707.
    >> Share

    April 2022
  119. VENKATESH KK, Lynch CD, Powe CE, Costantine MM, et al
    Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020.
    JAMA. 2022;327:1356-1367.
    >> Share

  120. LARKIN HD
    FDA Expands Empagliflozin Heart Failure Indication.
    JAMA. 2022;327:1219.
    >> Share

    March 2022
  121. SLOMSKI A
    Intensive Glycemic Treatment Reduces Diabetic Foot Ulcers.
    JAMA. 2022;327:1118.
    >> Share

    February 2022
  122. KUEHN BM
    COVID-19 Linked With Increased Incidence of Youth Diabetes.
    JAMA. 2022;327:711.
    >> Share

  123. KAMEL KS, Schreiber M, Harel Z
    Hypernatremia.
    JAMA. 2022;327:774-775.
    >> Share

  124. CHIPKIN SR
    Tirzepatide for Patients With Type 2 Diabetes.
    JAMA. 2022;327:529-530.
    >> Share

  125. DAHL D, Onishi Y, Norwood P, Huh R, et al
    Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    JAMA. 2022;327:534-545.
    >> Share

  126. SLOMSKI A
    New Data on Retinopathy in Youth-Onset Type 2 Diabetes.
    JAMA. 2022;327:416.
    >> Share

    January 2022
  127. RAY JG, Abdulaziz KE, Berger H
    Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.
    JAMA. 2022;327:388-390.
    >> Share

  128. RUBINO DM, Greenway FL, Khalid U, O'Neil PM, et al
    Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
    JAMA. 2022;327:138-150.
    >> Share

  129. KUEHN BM
    Younger Adults With Diabetes Miss Care, Disregard COVID-19 Precautions.
    JAMA. 2022;327:116.
    >> Share

    December 2021
  130. SLOMSKI A
    Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
    JAMA. 2021;326:2464.
    >> Share

  131. WANG L, Peng W, Zhao Z, Zhang M, et al
    Prevalence and Treatment of Diabetes in China, 2013-2018.
    JAMA. 2021;326:2498-2506.
    >> Share

  132. SLOMSKI A
    Statin Use Is Associated With Diabetes Progression.
    JAMA. 2021;326:2120.
    >> Share

    October 2021
  133. VOELKER R
    Supplement Marketers Are Warned About Diabetes Claims.
    JAMA. 2021;326:1472.
    >> Share

  134. CHU PJ
    Continuous Glucose Monitoring Use and Access Disparities.
    JAMA. 2021;326:1438.
    >> Share

  135. KARTER AJ, Gilliam LK, Dlott R
    Continuous Glucose Monitoring Use and Access Disparities-Reply.
    JAMA. 2021;326:1438.
    >> Share

  136. SLOMSKI A
    Cycling May Lower Mortality Risk in People Who Have Diabetes.
    JAMA. 2021;326:1246.
    >> Share

  137. COWART K, Carris NW
    Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
    JAMA. 2021;326:1329-1330.
    >> Share

  138. HERNANDEZ-NUNEZ W, Villareal-Perez JZ, Rodriguez-Gutierrez R
    Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.
    JAMA. 2021;326:1330.
    >> Share

  139. MARTENS TW, Beck RW, Bergenstal RM
    Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin-Reply.
    JAMA. 2021;326:1330-1331.
    >> Share

    September 2021
  140. SLOMSKI A
    Closed-Loop Insulin Delivery for Outpatients With Type 2 Diabetes.
    JAMA. 2021;326:1139.
    >> Share

  141. LITTLE RJ, Lewis RJ
    Estimands, Estimators, and Estimates.
    JAMA. 2021;326:967-968.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016